Table 1.

Effect of rPSGL-Ig treatment on hemodynamic parameters

Mouse genotypeTreatmentCirculating leukocytes, cells per μL bloodCenterline blood flow velocity, μm/sVessel diameter, μm
Before treatment*After treatmentBefore treatment*After treatment
WT Surgical stimulation 8200 ± 907 10 167 ± 2161 2157 ± 159 2664 ± 329 51.0 ± 4.1 
P-selectin−/− TNFα stimulation for 2 hours 30 minutes 4566 ± 753 5 200 ± 1159 2470 ± 413 2891 ± 278 39.8 ± 2.7 
E-selectin−/− P-selectin blocking antibody + heparin + 6 hours of TNFα 3400 ± 184 3 500 ± 217 2564 ± 357 2782 ± 427 39.4 ± 5.2 
Mouse genotypeTreatmentCirculating leukocytes, cells per μL bloodCenterline blood flow velocity, μm/sVessel diameter, μm
Before treatment*After treatmentBefore treatment*After treatment
WT Surgical stimulation 8200 ± 907 10 167 ± 2161 2157 ± 159 2664 ± 329 51.0 ± 4.1 
P-selectin−/− TNFα stimulation for 2 hours 30 minutes 4566 ± 753 5 200 ± 1159 2470 ± 413 2891 ± 278 39.8 ± 2.7 
E-selectin−/− P-selectin blocking antibody + heparin + 6 hours of TNFα 3400 ± 184 3 500 ± 217 2564 ± 357 2782 ± 427 39.4 ± 5.2 

Inhibitor treatment was 100 mg/kg throughout.

*

At 2 minutes before treatment.

At 2 minutes after treatment

or Create an Account

Close Modal
Close Modal